The American Association of Clinical Endocrinologists and American College of Endocrinology developed new osteoporosis guidelines that suggest all postmenopausal women aged 50 years and older be ...

Treatments for postmenopausal osteoporosis were generally misaligned with current guidelines among women at very high risk for fracture.

The UK National Osteoporosis Guideline Group (NOGG) has published new national recommendations for the prevention and treatment of osteoporosis. The updated guideline reviews the assessment and ...

Osteoporosis occurs more commonly in women, for whom medical guidelines recommend universal screening after age 65. But about ...

An updated Canadian osteoporosis guideline emphasizes the need to assess older patients of both sexes for risk for fractures. It also urges clinicians to provide advice on exercise and nutrition and, ...

Please provide your email address to receive an email when new articles are posted on . “We are in need of new osteoporosis screening and treatment algorithms, particularly in young postmenopausal ...

Osteoporosis is preventable and treatable, but only a small proportion of people at risk for fractures are evaluated and treated, according to new osteoporosis guidelines written by an expert panel ...

Clinicians should screen women 65 and older for bone density and osteoporosis, according to the U.S. Preventive Services Task Force. The task force, an independent panel of disease prevention experts, ...

Over the last 20 years, bone fracture rates in women have declined thanks to osteoporosis screening and treatment. But increasingly, experts say, the emphasis on women and osteoporosis has fostered a ...

The Endocrine Society has issued an update to the organization’s 2019 clinical practice guideline on pharmacologic management of osteoporosis to include romosozumab. In an effort to provide the most ...

It’s no secret that women “of a certain age” are at risk for fractures from osteoporosis. But less clear is what to do about it. After reports about serious, although rare, side effects — such as ...

Peter L. Salgo, MD: Let’s talk about the National Osteoporosis Foundation. Funny we should talk about that. Claire Gill: Yes. Peter L. Salgo, MD: What are their guidelines? What do they recommend ...